Renovascular Hypertension and Stenosis

J. Modrall
{"title":"Renovascular Hypertension and Stenosis","authors":"J. Modrall","doi":"10.2310/vasc.3042","DOIUrl":null,"url":null,"abstract":"Renal artery stenosis (RAS) may present clinically as an incidental radiographic finding in an asymptomatic patient, or it may be the etiology of renovascular hypertension or ischemic nephropathy. Incidental RAS should be treated medically. The available clinical trial data suggest that medical management is the primary treatment for presumed renovascular hypertension. Renal artery stenting should be reserved for patients who fail medical therapy. When renal artery stenting is contemplated for presumed renovascular hypertension or ischemic nephropathy, clinical studies suggest that there are clinical predictors of outcomes that may be useful in identifying patients with a higher probability of a favorable clinical response to stenting. Clinical predictors of a favorable blood pressure response to renal artery stenting include (1) a requirement of four or more antihypertensive medications, (2) preoperative diastolic blood pressure greater than 90 mm Hg, and (3) preoperative clonidine use. The only clinical predictor of improved renal function with stenting is the rate of decline of estimated glomerular filtration rate (eGFR) in the weeks prior to stenting. Patients with a more rapid decline in eGFR have a higher probability of improved renal function after stenting compared with those with relatively stable eGFR prior to stenting. Finally, surgical renal artery revascularization remains a viable option but is usually reserved for younger, fit patients with unfavorable anatomy for stenting. Pediatric renovascular disease responds poorly to endovascular therapy and requires a surgical plan to address both renal artery stenoses and concomitant abdominal aortic coarctation if present. Renal artery stenosis in pediatric patients is best treated with reimplantation of the renal artery or interposition grafting using the autogenous internal iliac artery as a conduit. \nThis review contains 39 references, 15 figures, and 3 tables.\nKey Words: chronic kidney disease, hypertension, renal artery stenosis, renovascular, stenting","PeriodicalId":413935,"journal":{"name":"DeckerMed Vascular and Endovascular Surgery","volume":"58 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"DeckerMed Vascular and Endovascular Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2310/vasc.3042","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Renal artery stenosis (RAS) may present clinically as an incidental radiographic finding in an asymptomatic patient, or it may be the etiology of renovascular hypertension or ischemic nephropathy. Incidental RAS should be treated medically. The available clinical trial data suggest that medical management is the primary treatment for presumed renovascular hypertension. Renal artery stenting should be reserved for patients who fail medical therapy. When renal artery stenting is contemplated for presumed renovascular hypertension or ischemic nephropathy, clinical studies suggest that there are clinical predictors of outcomes that may be useful in identifying patients with a higher probability of a favorable clinical response to stenting. Clinical predictors of a favorable blood pressure response to renal artery stenting include (1) a requirement of four or more antihypertensive medications, (2) preoperative diastolic blood pressure greater than 90 mm Hg, and (3) preoperative clonidine use. The only clinical predictor of improved renal function with stenting is the rate of decline of estimated glomerular filtration rate (eGFR) in the weeks prior to stenting. Patients with a more rapid decline in eGFR have a higher probability of improved renal function after stenting compared with those with relatively stable eGFR prior to stenting. Finally, surgical renal artery revascularization remains a viable option but is usually reserved for younger, fit patients with unfavorable anatomy for stenting. Pediatric renovascular disease responds poorly to endovascular therapy and requires a surgical plan to address both renal artery stenoses and concomitant abdominal aortic coarctation if present. Renal artery stenosis in pediatric patients is best treated with reimplantation of the renal artery or interposition grafting using the autogenous internal iliac artery as a conduit. This review contains 39 references, 15 figures, and 3 tables. Key Words: chronic kidney disease, hypertension, renal artery stenosis, renovascular, stenting
肾血管性高血压和狭窄
肾动脉狭窄(RAS)可能在临床表现为无症状患者的偶然影像学发现,也可能是肾血管性高血压或缺血性肾病的病因。偶发性RAS应进行医学治疗。现有的临床试验数据表明,医疗管理是推定肾血管性高血压的主要治疗方法。肾动脉支架植入术应保留给药物治疗失败的患者。当考虑肾动脉支架植入术治疗推定的肾血管性高血压或缺血性肾病时,临床研究表明,有临床预测结果的指标可能有助于识别对支架植入术有良好临床反应可能性较高的患者。肾动脉支架置入术对血压有良好反应的临床预测因素包括(1)需要四种或四种以上的降压药,(2)术前舒张压大于90mmhg,(3)术前使用可定。支架置入术后肾功能改善的唯一临床预测指标是支架置入术前几周肾小球滤过率(eGFR)的下降率。与支架植入前eGFR相对稳定的患者相比,eGFR下降更快的患者在支架植入后肾功能改善的可能性更高。最后,手术肾动脉重建术仍然是一个可行的选择,但通常保留给年轻,适合的患者不利的解剖支架植入术。小儿肾血管疾病对血管内治疗反应不佳,如果存在肾动脉狭窄和伴随的腹主动脉缩窄,则需要手术计划。小儿肾动脉狭窄的最佳治疗方法是肾动脉再植或以自体髂内动脉为导管的间置移植术。本综述包含39篇文献,15张图,3张表。关键词:慢性肾病,高血压,肾动脉狭窄,肾血管,支架植入术
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信